Narayana Hrudayalaya Ltd. Revenue Breakdown – NSE:NH
NiveshIQ
NSE: NH · Healthcare
Narayana Hrudayalaya Ltd.
₹2,070.60▼ ₹2.20 (-0.11%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on NH. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Narayana Hrudayalaya Ltd.
Narayana Hrudayalaya Limited (NH) is a leading Indian healthcare services provider with a diverse range of medical and healthcare services, including oncology, cardiology, and neurosurgery. The company operates through its Medical and Healthcare Related Services segment, which accounted for ₹5,432 crore of its total revenue of ₹6,778 crore in the latest fiscal year. NH has a strong presence in India, with a network of hospitals and clinics across the country. The company has been expanding its services and has a growing presence in the international market, including the Cayman Islands. Despite recent challenges, including price pressure and accidents on national highways, NH has maintained its market position. The company's strong revenue growth and increasing demand for healthcare servic
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹4,988 Cr +112.30% | ₹5,483 Cr +9.90% | ₹7,896 Cr +44.00% |
| EBITDA Margin | 23.04% | 23.27% | 21.74% |
| Net Profit | ₹790.00 Cr +141.60% | ₹791.00 Cr +0.10% | ₹866.99 Cr +9.60% |
| EPS | ₹38.62 | ₹38.66 | ₹39.89 |
Annual figures in Indian Rupees (Crores). Source: BSE filings.
Recent News
Narayana Hrudayalaya: ₹1,500 ਕਰੋੜ ਦਾ ਕਰਜ਼ਾ ਚੁੱਕਣ ਅਤੇ ₹4.50 ਡਿਵੀਡੈਂਡ ਦੇਣ 'ਤੇ ਵਿਚਾਰ
Narayana Hrudayalaya: ₹1,500 ਕਰੋੜ ਦਾ ਕਰਜ਼ਾ ਚੁੱਕਣ ਅਤੇ ₹4.50 ਡਿਵੀਡੈਂਡ ਦੇਣ 'ਤੇ ਵਿਚਾਰ
🔒
+ 3 more stories about Narayana Hrudayalaya Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q4FY26 results: revenue ₹2, 594 Cr, PAT ₹230 Cr, EPS ₹11.22, EBITDA margin 20.8%. Growth context: revenue QoQ +20.6%, PAT QoQ +81.6%. Street verdict: inline, revenue surprise +1.8%, PAT surprise -3.5%.
Management commentary highlights order wins, a robust deal pipeline, and backlog growth as key near-term drivers, with s...
FY26 (last completed FY): revenue ₹7, 896 Cr, PAT ₹867 Cr, EBITDA margin 21.7%, EPS ₹39.89. Year-on-year: revenue YoY +4...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantEverything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for NH
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track NH alongside your other holdings
Unlock full NH research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Narayana Hrudayalaya Ltd.?
NiveshIQ detects active intelligence signals for Narayana Hrudayalaya Ltd. (NH) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Narayana Hrudayalaya Ltd.?
Narayana Hrudayalaya Ltd. operates in the Healthcare sector with a market capitalisation of ₹3,928,356.9L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.